InterCure Statistics

Total Valuation

InterCure has a market cap or net worth of ILS 243.56 million. The enterprise value is 375.75 million.

Market Cap	243.56M
Enterprise Value	375.75M

Important Dates

The next estimated earnings date is Thursday, November 28, 2024.

Earnings Date	Nov 28, 2024
Ex-Dividend Date	n/a

Share Statistics

InterCure has 45.77 million shares outstanding. The number of shares has increased by 0.82% in one year.

Current Share Class	n/a
Shares Outstanding	45.77M
Shares Change (YoY)	+0.82%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	39.60%
Owned by Institutions (%)	7.82%
Float	25.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.90
PB Ratio	0.55
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.73
EV / Sales	1.38
EV / EBITDA	47.36
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.33.

Current Ratio	1.78
Quick Ratio	1.15
Debt / Equity	0.33
Debt / EBITDA	19.01
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -13.61% and return on invested capital (ROIC) is -0.28%.

Return on Equity (ROE)	-13.61%
Return on Assets (ROA)	-0.23%
Return on Capital (ROIC)	-0.28%
Revenue Per Employee	1.01M
Profits Per Employee	-243,048
Employee Count	270
Asset Turnover	0.34
Inventory Turnover	1.48

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.18% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+16.18%
50-Day Moving Average	649.40
200-Day Moving Average	748.03
Relative Strength Index (RSI)	28.50
Average Volume (20 Days)	152,023

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, InterCure had revenue of ILS 272.67 million and -65.62 million in losses. Loss per share was -1.42.

Revenue	272.67M
Gross Profit	77.98M
Operating Income	-2.97M
Pretax Income	-61.99M
Net Income	-65.62M
EBITDA	2.95M
EBIT	-2.97M
Loss Per Share	-1.42

Full Income Statement

Balance Sheet

The company has 20.30 million in cash and 150.81 million in debt, giving a net cash position of -130.52 million or -2.85 per share.

Cash & Cash Equivalents	20.30M
Total Debt	150.81M
Net Cash	-130.52M
Net Cash Per Share	-2.85
Equity (Book Value)	462.12M
Book Value Per Share	9.64
Working Capital	161.94M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 28.60%, with operating and profit margins of -1.09% and -24.07%.

Gross Margin	28.60%
Operating Margin	-1.09%
Pretax Margin	-22.73%
Profit Margin	-24.07%
EBITDA Margin	1.08%
EBIT Margin	-1.09%
FCF Margin	n/a

Dividends & Yields

InterCure does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.82%
Shareholder Yield	-0.82%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on April 8, 2021. It was a reverse split with a ratio of 0.2247564764.

Last Split Date	Apr 8, 2021
Split Type	Reverse
Split Ratio	0.2247564764

Scores

InterCure has an Altman Z-Score of 0.88. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.88
Piotroski F-Score	n/a